SCHEMBL7232290

SCHEMBL7232290

O=C(Nc1cc(C(=O)Nc2cccc3cc(S(=O)(=O)O)ccc23)cc(C(=O)Nc2cccc3cc(S(=O)(=O)O)ccc23)c1)c1ccc(F)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGF1 P05230 1/20 0.59
▸ CASP6 P55212 2/20 0.57
▸ TIMP3 P35625 2/20 0.52
▸ MEN1 O00255 4/20 0.47
▸ KMT2A Q03164 4/20 0.47
▸ CTDSP1 Q9GZU7 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.45
▸ RHOA P61586 1/20 0.44
▸ KCNK3 O14649 1/20 0.44
▸ KCNK9 Q9NPC2 1/20 0.44
▸ ENPP3 O14638 1/20 0.43
▸ ENPP1 P22413 1/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ CYP3A4 P08684 2/20 0.43
▸ CYP2C19 P33261 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7231334 0.90 CASP6 (0.56) FGF1CASP6TIMP3MEN1KMT2A
SCHEMBL7223574 0.90 FGF1 (0.60) FGF1CASP6TIMP3MEN1KMT2A
SCHEMBL7233377 0.90 CASP6 (0.60) FGF1CASP6TIMP3MEN1KMT2A
SCHEMBL7230646 0.89 CASP6 (0.55) FGF1CASP6TIMP3MEN1KMT2A
SCHEMBL7233109 0.89 FGF1 (0.59) FGF1CASP6TIMP3MEN1KMT2A
SCHEMBL7230621 0.89 CASP6 (0.60) FGF1CASP6TIMP3MEN1KMT2A
SCHEMBL6240628 0.87 CASP6 (0.72) FGF1CASP6TIMP3MEN1KMT2A
SCHEMBL7230329 0.87 CASP6 (0.57) FGF1CASP6TIMP3MEN1KMT2A
SCHEMBL7224369 0.87 CASP6 (0.57) FGF1CASP6TIMP3MEN1KMT2A
SCHEMBL7224470 0.86 CD40 (0.59) FGF1CASP6TIMP3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6653321-B1 Stimulating kinase activity of insulin receptor; type II diabetes; hyperglycemia TELIK, INC. 2003-11-25 — — US disclosed
Send feedback